Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation
- PMID: 12788925
- DOI: 10.1074/jbc.M305308200
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation
Abstract
MeCP2 is a transcriptional repressor that contains an N-terminal methylated DNA-binding domain, a central transcription regulation domain, and a C-terminal domain of unknown function. Whereas current models of MeCP2 function evoke localized recruitment of histone deacetylases to specific methylated regions of the genome, it is unclear whether MeCP2 requires DNA methylation to bind to chromatin or whether MeCP2 binding influences chromatin structure in the absence of other proteins. To address these issues, we have characterized the complexes formed between MeCP2 and biochemically defined nucleosomal arrays. At molar ratios near 1 MeCP2/nucleosome, unmethylated nucleosomal arrays formed both extensively condensed ellipsoidal particles and oligomeric suprastructures. Furthermore, MeCP2-mediated chromatin compaction occurred in the absence of monovalent or divalent cations, in distinct contrast to all other known chromatin-condensing proteins. Analysis of specific missense and nonsense MeCP2 mutants indicated that the ability to condense chromatin resides in region(s) of the protein other than the methylated DNA-binding domain. These data demonstrate that MeCP2 assembles novel secondary chromatin structures independent of DNA modification and suggest that the ability of MeCP2 to silence chromatin may be related in part to its effects on large-scale chromatin organization.
Similar articles
-
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.Cell. 1997 Feb 21;88(4):471-81. doi: 10.1016/s0092-8674(00)81887-5. Cell. 1997. PMID: 9038338
-
The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.J Biol Chem. 2003 Feb 7;278(6):4035-40. doi: 10.1074/jbc.M210256200. Epub 2002 Nov 9. J Biol Chem. 2003. PMID: 12427740
-
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.Nucleic Acids Res. 2001 Nov 15;29(22):4598-606. doi: 10.1093/nar/29.22.4598. Nucleic Acids Res. 2001. PMID: 11713309 Free PMC article.
-
Chromosomal regulation by MeCP2: structural and enzymatic considerations.Cell Mol Life Sci. 2004 Sep;61(17):2163-7. doi: 10.1007/s00018-004-4177-x. Cell Mol Life Sci. 2004. PMID: 15338046 Free PMC article. Review.
-
Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.IUBMB Life. 2010 Oct;62(10):732-8. doi: 10.1002/iub.386. IUBMB Life. 2010. PMID: 21031501 Free PMC article. Review.
Cited by
-
The Molecular Functions of MeCP2 in Rett Syndrome Pathology.Front Genet. 2021 Apr 23;12:624290. doi: 10.3389/fgene.2021.624290. eCollection 2021. Front Genet. 2021. PMID: 33968128 Free PMC article. Review.
-
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.Neural Plast. 2012;2012:415825. doi: 10.1155/2012/415825. Epub 2012 Feb 9. Neural Plast. 2012. PMID: 22474603 Free PMC article. Review.
-
Genomic insights into MeCP2 function: A role for the maintenance of chromatin architecture.Curr Opin Neurobiol. 2019 Dec;59:174-179. doi: 10.1016/j.conb.2019.07.002. Epub 2019 Aug 17. Curr Opin Neurobiol. 2019. PMID: 31430649 Free PMC article. Review.
-
The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.Hum Genet. 2005 Jan;116(1-2):91-104. doi: 10.1007/s00439-004-1200-0. Epub 2004 Nov 11. Hum Genet. 2005. PMID: 15549394
-
Epigenetic Factors That Control Pericentric Heterochromatin Organization in Mammals.Genes (Basel). 2020 May 28;11(6):595. doi: 10.3390/genes11060595. Genes (Basel). 2020. PMID: 32481609 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources